Blueprint Medicines Corporation (BPMC) Covered Calls

Blueprint Medicines Corporation covered calls Blueprint Medicines Corpis a biopharmaceutical company. It is focused on improving the lives of patients with genomically defined diseases driven by abnormal kinase activation.

You can sell covered calls on Blueprint Medicines Corporation to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for BPMC (prices last updated Tue 4:16 PM ET):

Blueprint Medicines Corporation (BPMC) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
116.95 +0.14 98.33 120.38 422K - 7.3
Covered Calls For Blueprint Medicines Corporation (BPMC)
Expiration Strike Call Bid Net Debit Return
If Flat
Return If Flat
Aug 16 115 6.60 113.78 1.1% 16.1%
Sep 20 115 8.80 111.58 3.1% 18.9%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Extended Business Description

Blueprint Medicines Corp. is a biopharmaceutical company, which engages in developing of kinase inhibitors for genomically defined subsets of cancer patients. It has developed a platform that combines genomics with a novel library of kinase inhibitors, enabling the development of potent highly selective compounds against clear genomic driver targets. The company was founded by Chris Varma, Nicholas B. Lydon, Brian Druker, and Alexis Borisy in October 2008 and is headquartered in Cambridge, MA.